Kainos Medicine, Inc. (KOSDAQ:284620)
South Korea
· Delayed Price · Currency is KRW 1,168.00
-66.00 (-5.35%)
Last updated: Mar 31, 2025
Kainos Medicine Market Cap
Kainos Medicine has a market cap or net worth of 34.58 billion as of April 1, 2025. Its market cap has decreased by -68.29% in one year.
Market Cap
34.58B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
198.59
Stock Price
1,168.00
Market Cap Chart
Since June 9, 2020, Kainos Medicine's market cap has decreased from 434.22B to 34.58B, a decrease of -92.04%. That is a compound annual growth rate of -40.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 34.58B | -61.29% |
| Dec 30, 2024 | 89.33B | -25.94% |
| Dec 28, 2023 | 120.62B | 5.37% |
| Dec 29, 2022 | 114.48B | -59.11% |
| Dec 30, 2021 | 279.94B | -40.72% |
| Dec 30, 2020 | 472.24B | 8.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 396.83T |
| SK hynix | 137.33T |
| LG Energy Solution | 83.30T |
| Samsung Biologics | 74.66T |
| Hyundai Motor Company | 44.69T |
| Celltrion | 38.03T |
| Kia Corporation | 37.52T |
| KB Financial Group | 29.19T |